NICE retracts diabetic macular oedema drug refusal
Thousands of people with a devastating eye condition could be offered a potentially sight-saving treatment following a U-turn by the National Institute for Health and Clinical Excellence.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units